postoperative pain postoperative mobility M17
Conditions
Interventions
Group 1: ACB with Sol. Ropivacaini 75mg-20ml before the operation
Group 2: First ACB with Sol.Ropivacaini 75mg-20ml is done, continuing wth an additional iPACK block with Sol.Ropivacaini 75mg-30ml bef
Sponsors
Hospital of Traumatology and Orthopaedics
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: - elective unilateral total knee arthroplasty due to osteoarthritis, - BMI <38 kg/m2, - ASA I-III, - patient is motivated to follow the protocol of the trial.
Exclusion criteria
Exclusion criteria: - bilateral total knee arthroplasty, - allergy or intolerance to the trial medication, - long-term use of anticoagulants before surgery, - steroid therapy in the last year, - active malignancy, - neurological or balance problems, - the patient is already in another study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain at rest using numeric pain rating scale at 7-8 AM of the first postoperative day | — |
Secondary
| Measure | Time frame |
|---|---|
| Strength of quadriceps muscle using Oxford scale at 7-8 AM of of the first postoperative day | — |
Countries
Latvia
Contacts
Public ContactSergejs Zadoroznijs
Hospital of Traumatology and Orthopaedics / University of Latvia
Outcome results
None listed